搜尋
Purple Biotech Ltd
PPBT添加自選
1.400USD
-0.010-0.71%
收盤 07-31 16:00（美東）報價延遲15分鐘
10.60M總市值
虧損本益比TTM
關於 Purple Biotech Ltd 公司
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
Purple Biotech Ltd簡介
公司代碼PPBT
公司名稱Purple Biotech Ltd
上市日期Sep 03, 1978
CEOEfron (Gil)
員工數量9
證券類型Depository Receipt
年結日Sep 03
公司地址4 Oppenheimer St.
城市REHOVOT
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Israel
郵編7670104
電話97239333121
網址https://purple-biotech.com/
公司代碼PPBT
上市日期Sep 03, 1978
CEOEfron (Gil)
Purple Biotech Ltd公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Itzhak Israel
Mr. Itzhak Israel
Director
Director
--
--
Mr. Simcha Rock
Mr. Simcha Rock
Director
Director
--
--
Dr. Gil Ben-Menachem
Dr. Gil Ben-Menachem
Vice President - Business Development
Vice President - Business Development
--
--
Mr. Ido Agmon
Mr. Ido Agmon
Independent Director
Independent Director
--
--
Mr. Steven Steinberg
Mr. Steven Steinberg
Independent Director
Independent Director
--
--
Mr. Yisrael Gewirtz
Mr. Yisrael Gewirtz
Internal Auditor
Internal Auditor
--
--
Mr. Arie Weber
Mr. Arie Weber
Independent Director
Independent Director
--
--
Ms. Revital Stern-Raff
Ms. Revital Stern-Raff
Independent Director
Independent Director
--
--
Mr. Ran Tzror
Mr. Ran Tzror
Independent Director
Independent Director
--
--
Mr. Avraham Ben-Tzvi
Mr. Avraham Ben-Tzvi
General Counsel, Secretary
General Counsel, Secretary
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Itzhak Israel
Mr. Itzhak Israel
Director
Director
--
--
Mr. Simcha Rock
Mr. Simcha Rock
Director
Director
--
--
Dr. Gil Ben-Menachem
Dr. Gil Ben-Menachem
Vice President - Business Development
Vice President - Business Development
--
--
Mr. Ido Agmon
Mr. Ido Agmon
Independent Director
Independent Director
--
--
Mr. Steven Steinberg
Mr. Steven Steinberg
Independent Director
Independent Director
--
--
Mr. Yisrael Gewirtz
Mr. Yisrael Gewirtz
Internal Auditor
Internal Auditor
--
--
常見問題
Purple Biotech Ltd的前五大股東是誰？
Purple Biotech Ltd的前五大股東如下：Mr. Itzhak Israel
有多少機構持有Purple Biotech Ltd(PPBT)的股份？
截至2026Q1，共有40家機構持有Purple Biotech Ltd的股份，合計持有的股份價值約為121.71K，占公司總股份的13.10% 。與2025Q4相比，機構持股有所增加，增幅為86679.00。